Checklist 9: Data collection considerations from participants in follow-up studies

Checklist 9: Data collection considerations from participants in follow-up studies

 Participant’s exact location at the time of, and during, the release;  The duration of time participant was in the hazard zone;  The type of activity participant was performing during exposure;  Any protection participant may have had while in the hazard zone (e.g., clothing, PPE, shelter);  Cleaning or decontamination undertaken by the participant;  Any symptoms (e.g., burning, itching) the participant felt during the exposure and how long these symptoms lasted;  How participant currently feels;  Previous and current medical conditions;  Allergies;  Past and current use of alcohol, tobacco, and recreational drugs;  Medications used at the time of exposure and since;  Other exposures through hobbies (e.g., exposure to volatile organic compounds), recreational activities, and in their homes (e.g., running a diesel generator);  Whether participant visited a doctor and/or received treatment; and  Traumatic experiences such as loss of relatives, housing, or job.

[Levy, 2010; WHO, 2009]